153 related articles for article (PubMed ID: 23784459)
21. Evaluation of serum M30 and M65 activity in patients with stage-I endometrial cancer.
Camuzcuoğlu A; Sezgin B; Çelik H; Camuzcuoğlu H
J Obstet Gynaecol; 2019 Nov; 39(8):1112-1116. PubMed ID: 31177876
[TBL] [Abstract][Full Text] [Related]
22. Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.
Oweira H; Sadeghi M; Volker D; Mieth M; Zidan A; Khajeh E; Ghamarnejad O; Fonouni H; Weiss KH; Schmidt J; Lahdou I; Mehrabi A
Ann Transplant; 2018 Jun; 23():393-400. PubMed ID: 29880786
[TBL] [Abstract][Full Text] [Related]
23. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
Dive C; Smith RA; Garner E; Ward T; George-Smith SS; Campbell F; Greenhalf W; Ghaneh P; Neoptolemos JP
Br J Cancer; 2010 Feb; 102(3):577-82. PubMed ID: 20051949
[TBL] [Abstract][Full Text] [Related]
24. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of serum Ck18-M65 and M30 levels in patients with chronic hepatitis B combined with nonalcoholic steatohepatitis and liver fibrosis.
Dai L; Yan Y; Chen Q
Medicine (Baltimore); 2024 Jun; 103(23):e38342. PubMed ID: 38847670
[TBL] [Abstract][Full Text] [Related]
26. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
Liang J; Han T; Gao YT; Jing L; Ma Z
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
[TBL] [Abstract][Full Text] [Related]
27. Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.
Cummings J; Hodgkinson C; Odedra R; Sini P; Heaton SP; Mundt KE; Ward TH; Wilkinson RW; Growcott J; Hughes A; Dive C
Mol Cancer Ther; 2008 Mar; 7(3):455-63. PubMed ID: 18347133
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer.
Sugimoto M; Abe K; Hayashi M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hashimoto M; Hikichi T; Nozawa Y; Ohira H
Sci Rep; 2018 Nov; 8(1):16997. PubMed ID: 30451962
[TBL] [Abstract][Full Text] [Related]
29. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
[TBL] [Abstract][Full Text] [Related]
30. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
[TBL] [Abstract][Full Text] [Related]
31. Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients.
Ausch C; Buxhofer-Ausch V; Olszewski U; Schiessel R; Ogris E; Hinterberger W; Hamilton G
J Gastrointest Surg; 2009 Nov; 13(11):2020-6. PubMed ID: 19727975
[TBL] [Abstract][Full Text] [Related]
32. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
Cummings J; Ranson M; Lacasse E; Ganganagari JR; St-Jean M; Jayson G; Durkin J; Dive C
Br J Cancer; 2006 Jul; 95(1):42-8. PubMed ID: 16804528
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.
Esmaeil N; Moayedi B; Gharagozloo M; Maracy MR
Hemoglobin; 2013; 37(4):404-10. PubMed ID: 23600495
[TBL] [Abstract][Full Text] [Related]
34. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.
Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Aker S; Yilmaztepe A; Gurel S; Gulten M; Nak SG
World J Gastroenterol; 2007 Feb; 13(6):837-44. PubMed ID: 17352011
[TBL] [Abstract][Full Text] [Related]
35. Optimisation of circulating biomarkers of cell death for routine clinical use.
Greystoke A; Cummings J; Ward T; Simpson K; Renehan A; Butt F; Moore D; Gietema J; Blackhall F; Ranson M; Hughes A; Dive C
Ann Oncol; 2008 May; 19(5):990-5. PubMed ID: 18304966
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
[TBL] [Abstract][Full Text] [Related]
37. Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease.
Senturk T; Aydinlar A; Yilmaz Y; Oral AY; Ozdabakoglu O; Ulukaya E
Coron Artery Dis; 2009 Dec; 20(8):494-8. PubMed ID: 19770641
[TBL] [Abstract][Full Text] [Related]
38. Onset of heart failure determines the hepatic cell death pattern.
Herzer K; Kneiseler G; Bechmann LP; Post F; Schlattjan M; Sowa JP; Neumann T; Marggraf G; Erbel R; Gerken G; Canbay A; Jochum C
Ann Hepatol; 2011; 10(2):174-9. PubMed ID: 21502679
[TBL] [Abstract][Full Text] [Related]
39. Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes.
Chondrogiannis K; Hadziyannis E; Fassoulaki A
Indian J Med Res; 2014 Nov; 140(5):630-6. PubMed ID: 25579144
[TBL] [Abstract][Full Text] [Related]
40. Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy.
Wei X; Wei H; Lin W; Hu Z; Zhang J
Medicine (Baltimore); 2017 May; 96(20):e6807. PubMed ID: 28514295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
